EWA
TARS icon

EverSource Wealth Advisors’s Tarsus Pharmaceuticals TARS Stock Holding History

EverSource Wealth Advisors’s Portfolio TARS Stock Details TARS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.8K Buy
203
+180
+783% +$11.5K ﹤0.01% 2752
2026
Q1 		$1.61K Sell
23
-7
-23% -$489 ﹤0.01% 3709
2025
Q4 		$2.46K Sell
30
-29
-49% -$2.17K ﹤0.01% 3421
2025
Q3 		$3.51K Sell
59
-10
-14% -$492 ﹤0.01% 3304
2025
Q2 		$2.8K Buy
69
+55
+393% +$2.48K ﹤0.01% 3385
2025
Q1 		$719 Buy
14
+7
+100% +$346 ﹤0.01% 3338
2024
Q4 		$388 Buy
+7
New +$318 ﹤0.01% 3275

Other funds holding TARS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

EverSource Wealth Advisors's TARS Position: Q2 2026 in Review

EverSource Wealth Advisors increased its Tarsus Pharmaceuticals (TARS) stake by 783% in Q2 2026, buying an estimated $11.5K and bringing the position to 203 shares worth $12.8K. The position accounts for ﹤0.01% of the portfolio, ranked #2752.

EverSource Wealth Advisors first reported a position in TARS in Q4 2024 and has held it in 7 quarters since. 257 funds tracked by Wall St. Rank hold TARS as of Q2 2026.

  • EverSource Wealth Advisors held 203 shares of Tarsus Pharmaceuticals worth $12.8K as of Q2 2026.
  • EverSource Wealth Advisors bought 180 Tarsus Pharmaceuticals shares in Q2 2026, an estimated $11.5K.
  • Tarsus Pharmaceuticals made up ﹤0.01% of EverSource Wealth Advisors's portfolio in Q2 2026, its #2752 holding.
  • EverSource Wealth Advisors first reported a position in Tarsus Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
  • 257 funds tracked by Wall St. Rank held Tarsus Pharmaceuticals as of Q2 2026.

Based on EverSource Wealth Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.